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Abstract
Background: Copy number variants (CNVs) have been demonstrated to occur at a high frequency and are now
widely believed to make a significant contribution to the phenotypic variation in human populations. Array-based
comparative genomic hybridization (array-CGH) and newly developed read-depth approach through ultrahigh
throughput genomic sequencing both provide rapid, robust, and comprehensive methods to identify CNVs on a
whole-genome scale.
Results: We developed a Bayesian statistical analysis algorithm for the detection of CNVs from both types of
genomic data. The algorithm can analyze such data obtained from PCR-based bacterial artificial chromosome
arrays, high-density oligonucleotide arrays, and more recently developed high-throughput DNA sequencing.
Treating parameters–e.g., the number of CNVs, the position of each CNV, and the data noise level–that define the
underlying data generating process as random variables, our approach derives the posterior distribution of the
genomic CNV structure given the observed data. Sampling from the posterior distribution using a Markov chain
Monte Carlo method, we get not only best estimates for these unknown parameters but also Bayesian credible
intervals for the estimates. We illustrate the characteristics of our algorithm by applying it to both synthetic and
experimental data sets in comparison to other segmentation algorithms.
Conclusions: In particular, the synthetic data comparison shows that our method is more sensitive than other
approaches at low false positive rates. Furthermore, given its Bayesian origin, our method can also be seen as a
technique to refine CNVs identified by fast point-estimate methods and also as a framework to integrate array-CGH
and sequencing data with other CNV-related biological knowledge, all through informative priors.
Background
Stable but not static, the DNA of human genome is sub-
ject to a variety of heritable changes of different types,
which significantly contribute to the phenotypic differ-
ences of individuals in human populations. In addition
to the single nucleotide polymorphisms (SNPs), these
genetic changes also include the chromosomal structural
variations, such as insertions, deletions, duplications,
inversions, and translocations, on various genomic
scales. Recent studies showed that insertions, deletions,
and duplications of DNA segments of 1 kb or longer in
the genome– collectively referred to as the copy number
variants (CNVs)–occur at a much higher frequency than
previously expected [1-4]. A recent global study of
CNVs in the human genome showed that the regions of
CNVs covered more nucleotide content per genome
than SNPs [1]. It is now widely believed that CNVs are
as important as SNPs and other small genomic changes
in their contribution to the phenotypic variation in
human populations.
Currently, unbalanced structural variants can be
experimentally identified by methods based on microar-
ray technology, polymerase chain reaction, or DNA
sequence comparison. Array-based method is a natural,
high-throughput extension of the comparative genomic
hybridization (CGH) analysis, which was originally
developed as a method to reveal any regions of allele
loss or aneuploidy by fluorescence microscopy [5].
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high genomic resolution, have been used in several
recent array-CGH studies [4,6,7]. The last several years
have seen rapid advancement in the field of sequencing
technology. Novel methods [8-10] are being developed
to reduce the cost and increase the throughput by gen-
erating massive amounts of sequence that can be aligned
to the genomic reference. This development has made it
possible to resequence whole genomes from multiple
individuals.
Indeed, a major sequencing project, the 1000 Gen-
omes Project, has been launched to resequence the gen-
omes of at least a thousand people from around the
world using the new sequencing technologies to produce
the most detailed map of human genetic variation for
disease studies. As the technologies mature and their
uses spread, new sequencing-based methods to detect
structural variations have been developed to take advan-
tage of the massively parallel sequencing. In the read-
depth approach, after DNA fragments are sequenced
from one or both ends, the reads are mapped to the
genome and then counted in a non-overlapping sliding
window. Both methods provide a rapid, robust, and
comprehensive approach to identify CNVs on the
whole-genome scale.
Both array-CGH and read-depth sequencing generate
genomic copy number (GCN) data in a very similar for-
mat: they consist of genomic signal output indexed by
the genomic locations. The signals are log-ratios of nor-
malized intensities from the test sample to those from
the reference sample for array-CGH and sequence read
counts after mean subtraction for read-depth sequencing,
respectively. The goal of analyzing such data is to detect
CNVs by identifying regions with signals that are consis-
tently higher or lower than the normalized baseline.
Implicitly, there are two distinct and yet closely related
estimation problems: one is to estimate the number of
CNVs, and the other is to determine the boundaries and
the average signal strength of each of them. Many statis-
tical and computational methods have been developed to
identify CNVs in individual genomes. They include
approaches built on hidden Markov model [11-13] or in
a Bayesian framework [14-16]. Recently a method to
identify recurrent CNVs within a group of individuals
has also been proposed [17]. Based on their data analysis
approaches, algorithms that have been developed to ana-
lyze such data can be roughly grouped into three types:
some only smooth the raw log-ratio data and the regions
with log-ratios higher or lower than a preset threshold
are identified as CNVs [18,19], others estimate the num-
ber of CNVs and their boundaries directly using the ori-
ginal log-ratio data [20-23], and the rest use a combined
approach [24-27]. The relative performance of these algo-
rithms has been assessed [28].
Here we present a Bayesian statistical framework to
analyze both array-CGH and read-depth data. Treating
parameters that define the underlying genomic copy
number variation encoded in the data as random vari-
ables, our approach derives the posterior distribution of
those parameters given observed data. This statistical
method models the location of regional changes and
their corresponding associated copy number, and esti-
mates the overall noise level in the data at the same
time. Sampling from the posterior distribution using
Markov chain Monte Carlo (MCMC) simulation is able
to give both the best estimate and a corresponding
Bayesian credible interval for each parameter in the
model. We discuss how our model was derived and
implemented, and the empirical results from applying
our method to both microarray and sequencing data for
CNV discovery.
Statistical model
In the life sciences we are often faced with the task of
making inferences about some object of interest given
incomplete and noisy experimental data. In the case of
CNV study, we are primarily concerned with inferring
the number of the DNA copy number variations, their
locations, sizes, and corresponding copy numbers-asso-
ciated amplitude measurements, given the genomic copy
number data, which are log-ratios of sample and control
intensities measured on microarrays or read depths gen-
erated by shot-gun genomic sequencing. To demon-
strate the application of our method to the read-depth
data, we take a set of sequence reads from the 1000
Genomes Project and construct a ‘read-depth intensity
signal’ spectrum by first mapping the reads to the
human genome reference sequence and then counting
the number of reads in a sliding window, a procedure
that transforms sequencing data into array-like intensity
signal. We capture these unknown quantities in a prob-
ability model that relates them to the observed data.
Our model is Bayesian in essence as we assign prior dis-
tributions to parameters and use the posterior distribu-
tion function to estimate the underlying data generating
process. Given the posterior distribution, we then use
the Markov chain Monte Carlo method to fit the model.
By doing so, we get not only the best estimates for these
unknown parameters but also Bayesian credible intervals
for the estimations at the same time.
Given a set of genomic copy number data D ={ gk, xk},
k =1 ,2 ,. . . ,M,i nw h i c hgk is the sorted genomic loca-
tion of the kth data point, xk the signal at this location,
and M t h en u m b e ro fd a t ap o i n t s ,w et r yt oi n f e rt h e
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defined by the CNVs encoded in the data set with the
same measurement unit as xk. Assuming that the mea-
surements of CNVs are all step functions, the spectrum
ℱ can be written as
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where N is the number of ‘smoothed’ CNVs detectable
i nt h ed a t as e t ,a n dsj, wj, aj are the start genomic loca-
tion, the width, and the amplitude of the j-th CNV
respectively. Thus the ‘ideal’ data set corresponding to
D based on this model is F ={ gk, fk}, k = 1, 2, ..., M. For
simplicity, we assume that X1, X2,. . . ,XM measured in D
are independent random variables each subjected to
additive Gaussian noise around ℱ with a standard devia-
tion s.
Given the aforementioned model (Figure 1), the set of
parameters to be inferred from D is θ ={ N,( sj, wj, aj),
s
2}, j = 1, 2, ..., N. Sometime for convenience, instead of
reporting the estimate of wj, we report the estimate of
ej, the end of the j-th CNV (ej = sj + wj - 1). The condi-
tional probability distribution function p(θ|D)s u m -
marizes our inference about θ given the data and our
prior knowledge about the CGH spectrum ℱ.
Bayes’ theorem relates the posterior probability distri-
bution function p(θ|D) to the likelihood probability dis-
tribution function p(D|θ) that can be calculated from
the data and the prior probability distribution function
p(θ) that encodes the prior knowledge,
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where the normalization constant p(D)i so m i t t e df o r
simplicity.
Likelihood. Given the simplifying normality assump-
tion stated above, the likelihood function takes the form
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Prior. Given the discrete nature of CNVs, it is reason-
able to assume ap r i o r iindependence among all the
parameters in θ. We choose the following prior distribu-
tions:
▫ Uniform distributions for N, sj,a n dwj (j = 1, 2, ..., N):
￿ p(N)=1 / Nmax
￿ p(sj) = 1/(smax-smin)=1 / M
￿ p(wj)=1 / M
▫ Normal distribution for aj: p(aj)~  (τj, j
2)
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After rearrangement and removal of the constant
Nmax, we have
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Figure 1 The graphical representation of the proposed
Bayesian model. All quantities are shown as nodes in this directed
graph. The parameter triplets sj, wj, and aj (j = 1, 2, ..., N) are
combined together. The solid arrows indicate the modeled data set
F is determined by a logical function with parameters sj, wj, and aj (j
= 1, 2, ..., N), and the dashed arrows signify the stochastic
dependence of the real data set D on both F and the overall data
noise level s.
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Page 3 of 13where a, b, τj and j are the hyperparameters that
characterize the prior distribution. See the Implementa-
tion subsection below for their parameterization.
Posterior. Substituting the product of the likelihood
and the prior of equations (3) and (5) into equation (2),
we obtain
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For a given model {ℳ: θ Î Θ}, where N is known and
thus θ ={ ( sj, wj, aj), s
2}, j = 1, 2, ..., N, the posterior dis-
tribution of θ given the data D and the model ℳ can
be expressed as
p
e
M a j
N
jj j
(|) .
() // ( , ) / 

    D ∝
⋅
++ ++ − =
1
21 22
22
1
22 Σ (7)
Informative prior. If we have information on certain
parameters in θ, for example sj and wj,f r o ma ni n i t i a l
scan of data D, such information can be coded in an
informative prior to simplify subsequent parameter esti-
mation. For example, suppose we know N = 1, the CNV
starts at a certain place between genomic position a and
b, and its length is between c and d bp long. We code
such prior information as following:
▫ Uniform distributions for s1 and w1:
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Keeping priors on other parameters the same as
before, we have
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With this informative prior, the posterior is the same
as (7), but only none-zero for s1 Î[a, b] and w1 Î[c, d ].
This condition simplifies subsequent parameter estima-
tion, as s1 and w1 only need to be sampled in these two
intervals during MCMC simulation.
I ns o m ec a s e ,w eo n l yk n o wt h es t a r ta n dt h el e n g t h
of a particular CNV (similar to the case above) but still
have to estimate N and the parameters of the other
C N V s .T h i si sac a s et h a tm i x e st h eg e n e r a la n dt h e
special ones presented above. It is easy to show the
informative prior is a mix of (7) and (8):
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When analyzing clean read-depth data, if the ampli-
tude of the j-th CNV, aj, occurs discretely at several dif-
ferent values (for example aj Î{-c, c, 2c}, where c is the
genome-wide average haploid read depth), the prior dis-
tribution p(aj)o faj can be modeled naturally by a mul-
tinomial distribution.
Algorithm and implementation
Parameter estimation by Markov chain Monte Carlo
simulation
Analytically summarizing the posterior distribution p(θ|
D) is difficult. For example, even though in theory the
posterior expectation of an arbitrary function of θ, g(θ),
can be computed as
Eg g p d (() | ) ()( | ) ,      DD =∫
(9)
the calculation is usually impracticable for two rea-
sons. Firstly, p(θ|D) is only known up to some multipli-
cative constant due to the proportionality form of
equation (8). Secondly, even if the exact form of p(θ|D)
is known, given the number of parameters in θ (at least
four in a non-trivial case), the high dimensional integral
required in equation (8) is very difficult to be carried
out in practice and soon becomes intractable as the
number of parameters increases. However, Markov
chain Monte Carlo (MCMC) provides an alternative
whereby the posterior can be directly sampled to obtain
sample estimates of the quantities of interest. Thus
using a random sequence of K draws θ
(1), θ
(2), ..., θ
(K)
from p(θ|D), E(g(θ)|D) can be approximated by simply
taking the average of these draws. Similar methods can
be used to compute the posterior standard deviation  ˆ
or quantiles, probabilities that parameters take particular
values, and other quantities of interest.
The Gibbs sampling algorithm [29] was implemented
to sample from the target distribution {p(θ|D,ℳ): θ ÎΘ
⊆ ℝ
3N+1}. To do so, the Gibbs sampler first constructs
an aperiodic and irreducible Markov chain whose sta-
tionary distribution is p(θ|D,ℳ) in the state space Θ,
and then draws a sequence of random samples from
conditional distributions to characterize the joint target
distribution. More precisely, it was implemented by
(i) taking some initial values θ
(0); (ii) repeating for each t
= 1, 2, ..., T,w h e r eT is the preset number of iterations,
generating θi
(t) from p(θi
(t)| θ1
(t), ..., θi-1
(t), θi+1
(t-1), ...,
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(t-1),D,ℳ)f o ri = 1, 2, ..., ||θ||; (iii) continuing the
previous step for T times after the estimated target dis-
tribution ˆ(| , ) p  D  converges.
To calculate the conditional probabilities of sj and wj
required by the second step of the Gibbs sampling sta-
ted above, all possible s Î[g1, gM]a n dw Î[wmin, wmax]
are evaluated. Given the normality assumption about
the data, conjugate prior distributions of aj and s
2 can
be used to simplify the calculation of their conditional
probabilities. If the prior distribution of aj takes the con-
jugate from p(aj)~  (τj, j
2), the conditional distribu-
tion of aj given other parameters, the data D,a n dt h e
model ℳ is also a normal distribution as
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22 /( / / ))  jj w + where x j is the average log-
ratios of probe intensities in the j-th CNV. Given
the conjugate prior distribution of s
2, p(s
2)~ℐnvmma
(a, b), the conditional distribution of s
2
given other parameters, the data D,a n dt h em o d e l
ℳ is also an inverse gamma distribution,
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Model selection using Bayes factor
Model selection is required to determine N, the number
of CNVs, as different N changes the model parameteri-
zation θ. Suppose that the data D have arisen under one
of the two models, {ℳ1: θ1 Î Θ1}a n d{ ℳ2: θ2 Î Θ2},
according to a probability density p(D |ℳ1)o rp(D |
ℳ2).
Given prior probabilities p(ℳ1)a n dp(ℳ2)=1-p
(ℳ1), the data produce posterior probabilities p(ℳ1|D)
and p(ℳ2|D)=1 -p(ℳ1|D). From Bayes’ theorem, we
obtain
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For a given model {ℳ: θ Î Θ}, p(D |ℳ)c a nb e
approximated by the sample harmonic mean likelihoods,
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based on K MCMC draws θ
(1), θ
(2),. . . ,θ
(K) from the
posterior distribution p(θ|D). The harmonic mean
estimator is consistent since ˆ (| ) (| ) pp D HM D  →
as K ® + ∞. It may, however, have infinite variance
across simulations. To solve this problem, Newton and
Raftery [30] proposed an alternative estimator,
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which does not display any of the instability of
ˆ (| ) pHM D  .W ei m p l e m e n t e d ˆ (| ) p4 D  to calculate
the Bayes factor for model comparison
Implementation
Our method, including the Markov chain Monte Carlo
simulation and the model comparison, is currently
implemented in R [31]. To use non-informative priors
for our Bayesian inference, we set τj =0a n dj = 100,
which effectively makes the prior distribution of aj flat
around 0. We also assign 1 to both a and b for the
inverse gamma distribution of s
2.W et e s t e dv a r i o u s
values of the hyperparameters (τj, j, a,a n db), and the
simulation results showed that the parameter inference
was insensitive to the values assigned to these hyper-
parameters, which is expected given the large number of
data points. A 500-iteration MCMC simulation of the
posterior distribution (7) given a data set with M =5 0 0
and N = 1 took 126 seconds of CPU time on a personal
computer with one 1400-Mhz x86 Intel processor and
500 MB RAM. To assess the convergence of the Markov
chain after 500 iterations, we started multiple chains
from different values of θ
(0). The simulations showed
that after initial dozens of iterations all chains converged
to the same solution. Based on this observation, we con-
cluded that 500 iterations were sufficient for Bayesian
inference in this case. We used the same convergence
diagnostic for all inferences.
Because of great computational intensity of the
MCMC simulation, to process a large GCN data set, we
use a ‘divide and conquer’ strategy. We first sort array/
sequencing features from each chromosome according
to their genomic locations and then group 1000 conse-
cutive features into subsets for parallel processing on a
computer cluster.
Results
Simulated array-CGH data
We first used simulated array-CGH data sets to test our
Bayesian model and its implementation. To generate
such synthetic data, we first specified values for the
parameters in θ ={ N,( sj, wj, aj), s
2}, j =1 ,2 ,. . . ,N,i n
which N and (sj, wj, aj) define the artificial genomic
CNV structure encoded as a step function and s
2
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lated data were then generated by superimposing this
predefined step function with random Gaussian noise.
Typical simulated array data with one and multiple
CNVs are shown in Figures 2A and 3A respectively.
The simulated array data (M = 500) plotted in Figure
2A were generated with θ ={ N =1 ,( s1 = 200, w1 = 50, a1
=1 . 5 ) ,s
2 =0 . 4
2}, which was to be estimated. Taking N =
1, we started the Markov chain at some random θ
(0) =
{(s1 = 100, w1 =0 ,a1 =0 ) ,s
2 =0 . 1
2} and ran it for 500
iterations. The sampling results are shown in Figure 2C-
F. As the parameter trace plots (Figure 2G-J) show, the
Markov chain quickly converged to stationarity after
approximately ten iteration s( F i g u r e2 B ) .T oe r ro nt h e
side of caution, we discarded the samples from the first
100 iterations as the ‘burn-in’ samples and estimated the
parameter values from the rest 400 samples, which gave
ˆ {(ˆ , ˆ , ˆ .) , ˆ .}  == = = = sw a 11 1
22 200 50 1 57 0 38 given
N =1 .
Remarkably, all these samples have the very similar s1
and w1, which are 200 and 50 respectively. Because of
this small variation in their estimation, the estimates of
s1 and w1 from the data are of extremely high confi-
dence. The distributions of a1 and s in the 400 samples
are approximately normal as  (1.57, 0.057
2)a n d
 (0.38, 0.012
2) respectively. Based on their normal dis-
tributions, we can easily calculate a Bayesian credible
interval for both a1 and s. For example, a 95% Bayesian
credible interval for a1 is [1.46, 1.68], which suggests
that, after observing the data, there is a 95% chance that
the average log-ratio of intensities in this CNV falls
between 1.46 and 1.68.
We also simulated array-CGH data (M = 1000) with
multiple CNVs (Figure 3A) using θ ={ N =4 ,( s1 = 100,
w1 = 30, a1 =0 . 7 ) ,( s2 = 200, w2 =2 0 ,a2 = -0.3), (s3 =
400, w3 = 80, a3 = 1.5), (s4 = 600, w4 = 90, a4 = -0.6), s
2
=0 . 1
2}. To identify the CNVs encoded in this data set,
first the model-specific parameters {(sj, wj, aj), s
2}, j =1 ,
2, ..., N were estimated under different models with N =
0, 1, ..., 5. In Figure 3A, the scatter plot of the multi-
CNV array-CGH data are overlaid with the segmenta-
tion found by our algorithm using different models. The
figure shows that the most prominent CNV was identi-
fied first when the number of CNVs, N,w a ss e tt o1
and less prominent CNVs were progressively identified
as the model became more permissive (i.e., N was
increased). To select the most plausible model from
which the observed data were generated, each of the
models with N =1 ,2 ,3 ,4 ,5w a st h e nc o m p a r e dw i t h
the basal, null model (N = 0). Quantification of these
comparisons by the logarithm of the Bayes factor, which
gives 691.02, 926.94, 1091.13, 1556.23, and 1173.67
respectively, clearly indicates that the model with N =4
is the best model among the ones tested (Figure 3B). It
is noteworthy that since the numbers aforementioned
are the logarithms of the Bayes factor the actual increase
in the marginal evidence p(D|M) between neighboring
models is very substantial. For example, the increase in
the marginal evidence from N =3t oN =4i se
1556.23-
1091.13 = e
465.11 ≈ 9.86 × 10
201 fold.
Lai et al. [28] examined the performance of 11 array-
CGH data analysis methods: CGHseg, quantreg,
CLAC, GLAD, CBS, HMM, wavelet, lowess,
ChARM, GA, and ACE. To assess the performance of
our algorithm in conjunction with these methods, we
used the same simulated data as Lai et al. used for the
assessment in their study to calculate the true positive
rates (TPR) and the false positive rates (FPR) as the
threshold for determining a CNV is varied. See Lai at al.
for the definitions of TPR and FPR and the details of
the simulated data sets. We calculated the receiver
operation characteristic (ROC) curve of our algorithm
using the most noisy (thus the lowest signal-to-noise
ratio, SNR = 1) data set with the CNV width of 40
probes. This ROC curve, together with the ROC curves
of other array-CGH methods based on the same data
set, was plotted in Figure 4. These curves show that our
Bayesian algorithm is appreciably more sensitive than all
other methods at low (< 10%) false positive rates. We
need to point out that the comparison was conducted in
a fair manner, if not to the disadvantage of our method:
all the results from Lai et al. were used directly without
modification and our method has no free parameters to
tune.
Glioblastoma Multiforme array-CGH data
Lai et al. [28] compared 11 different array-CGH data
analysis algorithms that are based on diverse statistical
or computational techniques. In addition to testing
those methods using simulated data, they also character-
ized their performance on chromosomal regions of
interest in real data sets obtained from patients with
Glioblastoma Multiforme (GBM) [32]. These cDNA
microarray-based data sets were generated by CGH-pro-
filing copy number alterations across 42,000 mapped
human cDNA clones, in a series of 54 gliomas of vary-
ing histogenesis and tumor grade.
I tw a so b s e r v e dt h a tt h eG B Md a t ac o n t a i nam i x t u r e
of larger CNV regions with low amplitude and smaller
ones with high amplitude. These two types of array-
CGH data are nicely represented by data sets GBM31
and GBM29 respectively (Figure 5A-B). In sample
GBM31, a large region on chromosome 13 was lost, and
the overall magnitude of this loss is very low due to the
low penetrance of this genetic variation in tumor cells
in this sample. In sample GBM29, on the other hand,
there are three high-amplitude small duplications. To
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Figure 2 Parameter estimation by MCMC simulation for a simulated array-CGH data set. (A) The log-ratio vs. probe genomic index plot of
a simulated one-CNV array-CGH data set. The data D (M = 500) were generated with θ ={ N =1 ,( s1 = 200, w1 = 50, a1 = 1.5), s
2 = 0.4
2}. (B) The
logarithm of the posterior probability (calculated up to some multiplicative constant) at consecutive 500 MCMC sampling iterations. In the
stationary phase, the posterior probability of the MCMC-sampled parameter values given data D, p(|)   D , fluctuates closely beneath the
maximum value p(θ|D). (C-F) Histograms of the 500 estimates of s1, w1, a1, and s respectively. (G-J) Traces of the estimates of s1, w1, a1, and s
through the consecutive 500 MCMC sampling iterations.
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Page 8 of 13evaluate our Bayesian approach in a comparable way, we
also used these two GBM data sets processed and uti-
lized by Lai et al. to test our method.
Figures 5A and 5B show the array-CGH profiles of
chromosomes 13 and 22 in Glioblastoma
Multiforme samples GBM31 and GBM29, respectively,
overlaid with the segmentation found by our
algorithm. As seen in Figure 5A, our algorithm detected
the single broad proximal deletion of part of chromo-
some 13 in GBM31, spanning from the 59
th to the
542
nd probe with a log-ration intensity at -0.30
({ ( , , . ) , . }   == = = − = se a 11 1
22 59 542 0 30 0 38 
with corresponding standard deviations,
      ˆˆ ˆ ˆ ˆ { ( ., ., .) , .} == = = − = sea 111
2 24 0 31 9 00 2 00 1 ,f o rc a l c u l a t -
ing each Bayesian credible interval). The breakpoint ˆ e1
at the probe genomic index 542 was also identified by
all the programs that detected this deletion in the test
conducted by Lai et al. The other breakpoint ˆ a1 at 59
was again found by CLAC and ACE evaluated in the
same test [28]. The small sample standard deviations in
 ˆ connote the reliability of the parameter estimation
despite a rather low signal to noise ratio of the GBM31
data. Our algorithm also detected all three high-ampli-
tude amplifications of parts of chromosome 22 in
GBM29 (Figure 5B). Even though there are only four
probes separating the first two amplifications, our
method still segmented them clearly. Moreover, our
method also pinpointed the six breakpoints of these
three CNVs (their sample standard deviations are all
zeros), which makes these predictions highly reliable.
b-globin high-density array-CGH data
One recent significant development in the microarray
technology is the emergence of the tiling array technol-
ogy, which can be used to cover large genomic regions
or even an entire genome on one or several microarrays
in an unbiased fashion by using oligonucleotides (a.k.a.
tiles) uniformly sampled from presented genomic
sequences. The current trend is to migrate from PCR-
based arrays to tiling arrays for a much higher resolu-
tion and a comprehensive genomic coverage.
In a recent study [7], in order to test the resolution
limits of tiling arrays when they are used with CGH for
CNV discovery, Urban et al. designed microarrays that
tile through 100 kb of the b-globin locus with overlap-
ping isothermal oligonucleotides spaced 9 bp apart
alone the tiling path. They compared the test DNA
from a patient with a known heterozygous deletion of
622 bp in the b-globin locus and the reference DNA
pooled from seven individuals without this chromoso-
mal aberration. Figure 5C shows the array-CGH profile
of the b-globin locus of the patient overlaid with the
segmentation ({ ( , , . ) , . } )   == = = − = sea 48 88 0 36 0 25
22 
found by our algorithm. This deletion in the b-globin
locus was detected, and the estimate of its length, ˆ w ,
corresponding to 641 bp in the genomic coordinate sys-
tem, is highly accurate in comparison with the actual
length of the deletion (622 bp).
Read-depth genome resequencing data
The genome of a Utah resident with Northern and Wes-
tern European ancestry from the CEPH collection
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Figure 4 The ROC curves of array-CGH data analysis methods.
(A) The complete plot. All curves were calculated using the same
data set. They show that our Bayesian algorithm (black line) is
appreciably more sensitive than all other methods (gray lines) at
low (< 10%) false positive rates. (B) Details of the ROC curves in the
low FPR region of (A) inside the box with dashed border. See Lai et
al. [28] for the identities of the gray ROC curves. TPR, the true
positive rate; FPR, the false positive rate.
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Page 9 of 13(NA12878) has been sequenced by the 1000 Genomes
Project using both the 454 paired-end and the Illumina
shot-gun sequencing technologies, which produced long
(120-bp) sequence reads with low coverage (0.5×) and
short (50-bp) ones with high coverage (40×),
respectively.
After using these two sequence sets to generate the
‘known’ genomic deletions in and the read-depth data
from this individual, we apply our method to the read-
depth data and compare the finding with the ‘known’
genomic deletions. Despite a very low sequencing depth,
we are able to use 454 reads to detect several large
genomic deletions in this individual based on the
gapped (i.e., ‘split’) alignment of some of these long
reads. These deletions are taken as known, and we use a
2653-bp deletion on chromosome 6 from 32,669,938 to
32,672,591 to illustrate the application of our read-depth
method. After mapping approximately 2.4-billion 50-bp
Illumina reads to the human reference genome, we
count the number of reads in a 200-bp non-overlapping
sliding window to produce the read-depth data. Figure
6A shows the read distribution profile based on the Illu-
mina short reads surrounding the 2653-bp deletion
locus.
Our method detected this deletion in the read-depth
data and estimated its parameters to be
ˆ {( ˆ , ˆ , ˆ .) , ˆ .}   == = = − = se a 32670400 32672500 51 20 27 73
22  .
To investigate how the sequencing depth affects the
estimation of the start and the end positions of a CNV,
we simulate a series of sequencing depths by randomly
sampling (without replacement) different numbers of
mapped Illumina reads and then apply our method to
the simulated data. The standard deviation in the esti-
mates of the start and the end positions, s and e, reflects
how well these two parameters can be estimated from
the read-depth data. In figure 6B we plot the averaged
standard deviation in the estimates of the s and e at
different sequencing depths. It is clear as the sequencing
depth decreases from the original depth (37×) the
estimates of the terminal positions become less accurate.
In fact, when the coverage is below 1×, it becomes very
difficult to find the deletion at all.
Discussion and Conclusion
The Metropolis-Hastings and the Gibbs sampling algo-
rithms, two Markov chain Monte Carlo simulation
methods, have been widely used for Bayesian inference.
Developed by Metropolis et al. [33] and subsequently
generalized by Hastings [34], the Metropolis-Hastings
algorithm generates, based on the current state and a
pre-selected proposal density, candidate states that are
accepted (or rejected) stochastically with a certain
acceptance probability but then retains the current value
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Figure 5 CNV profiles of three experimental array-CGH data
sets. Probe segmentation of (A) GBM31, (B) GBM29, and (C) b-
globin small deletion array-CGH data. In all cases, the MCMC
sampler was run for 1000 iterations. The first 100 samples were
discarded as the ‘burn-in’ samples, and the mean and the standard
deviation of each parameter were estimated from the rest 900
samples. The estimated means are plotted as a step function (the
black line), and the estimated standard deviations are indicated as
yellow boxes, each defined by mean ± 1.96 × standard deviation,
which corresponds to a 95% credible interval.
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Page 10 of 13when rejection takes place. Gibbs sampling [29] draws a
sequence of random samples from conditional distribu-
tions of unknown parameters to characterize their joint
target distribution. In fact, the Gibbs sampling can be
regarded as a special case of the Metropolis-Hastings
algorithm as the acceptance probability is always one–
i.e., every proposal is automatically accepted.
For our Bayesian analysis of genomic copy number
data, we implemented both the random walk Metropo-
lis-Hastings (RWMH) and the Gibbs sampling algo-
rithms and observed that in this application Gibbs
sampling is much more suitable for parameter inference.
RWMH worked well for one-CNV data. However, if the
data contain two widely separated CNVs, it can only
identify one of them but not both. To investigate this
limitation, we plotted the landscape of the posterior
probability distribution in a two-dimensional parameter
space. A two-CNV data set D (M = 700) with θ ={ N =
2, (s1 = 100, w1 =2 0 ,a1 =2 ) ,( s2 =6 0 0 ,w2 =2 0 ,a2 =
2), s
2 =0 . 4
2} was first simulated, and then the posterior
probability was evaluated with various combinations of
s1 and s2 while all other parameters were kept fixed at
their true values.
The surface plot in Figure 7A shows a global maxi-
mum peak located at s1 = 100 and s2 = 600 as expected
and an overall very rugged posterior distribution ‘ter-
rain’: the landscape is full of local maxima with, espe-
cially, two prominent ‘ridges’ of local maxima at s1 =
100 and s2 = 600, respectively. It is clear from Figures
7A and 7B that if the Markov chain of RWMH gets to a
local maximum on the ridge at s1 =1 0 0o rs2 = 600 but
fortuitously far from the global maximum, it will be
trapped on the ridge and practically cannot reach the
global peak if the random update interval is small
(which is almost always the case). Based on these obser-
vations, we chose the Gibbs sampling algorithm for our
Bayesian analysis of the genomic copy number data as
the Gibbs sampler is well suitable to explore this ‘ridged’
terrain by using full conditionals to scan the landscape
along ridges to find the global maximum.
As the ROC curves in Figure 4 show, our Bayesian
a l g o r i t h mi st h em o s ts e n s i t i v em e t h o da tl o w( <1 0 % )
false positive rates. This means that at a given low FPR
our method can identify more true positive probes
inside CNVs than other methods. When the FPR is
higher, it is less sensitive than several methods, most of
which find CNVs through data smoothing. However,
this is hardly a disadvantage, as at high false positive
rates the list of identified CNVs is awash with false posi-
tives, rendering the whole list practically unusable.
In addition to the improved sensitivity, our method
also has several distinct advantages innate to its Baye-
sian approach. The confidence on an estimated para-
meter value can be assessed through its Bayesian
credible interval. Akin to a confidence interval but with
an intuitive probabilistic interpretation, a Bayesian cred-
ible interval is a range of values that contains the true
parameter value with a certain probability. Through sto-
chastic simulation, it is straightforward to summarize
the otherwise analytically intractable joint posterior dis-
tribution of the unknown parameters and compute both
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Figure 6 Identification of CNV in the read-depth data. (A) CNV
profile of a deletion locus in a read-depth data set. Short reads
generated for a CEPH individual were mapped to the human
reference genome and then counted in a 100-bp non-overlapping
sliding window to produce the read-depth data. The counts are
centered to their mean. The MCMC sampler was set up in a similar
fashion as in the previous cases. The estimated means are plotted
as a step function, and the 95% credible intervals as yellow boxes.
The 2653-bp deletion, which is found by long sequence reads that
encompass this deletion locus and thus split around it when
aligned to the reference sequence, is taken as known and shown as
the thin green line on a lower track. (B) The averaged standard
deviation in the estimates of the start and the end positions (s and
e) at different sequencing depths. The S.D. unit is the window size,
which is 200 bp in this case.
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Page 11 of 13the best estimate and a corresponding Bayesian credible
interval for each parameter in the model. The availabil-
ity of the intervals for sj, ej, and aj–the start and the end
genomic locations and the copy number of each CNV–
is unique to our Bayesian method, and these credible
intervals can be especially useful.
Recent years have seen fast development of methodol-
ogies in different frameworks to detect CNVs in array-
CGH data. For example, to detect CNV breakpoints,
Shah et al. used a modified hidden Markov model
(HMM) that is robust to outlier probes [13], while
Rueda and D’az-Uriarte used a nonhomogeneous HMM
fitted via reversible jump MCMC [12]. Pique-Regi et al.
used piecewise constant (PWC) vectors to represent
genome copy numbers and sparse Bayesian learning to
detect CNV breakpoints [16]. Other methods for seg-
menting array-CGH data have also been implemented,
including using Bayesian change point analysis [15], a
spatially correlated mixture model [14], a Bayes regres-
sion model [35], and wavelet decomposition and thresh-
olding [36].
Due to the computational intensiveness of its MCMC
simulation, the method that we present here can be
most advantageously used to refine CNVs detected by
fast point-estimate methods. It could also be seen as a
basic genomic copy number data analysis framework,
amenable for several possible extensions. Firstly, due to
t h en a t u r eo ft h eg e n o m i cs e q u e n c ed u p l i c a t i o n sa n d
deletions, the signal measurements of CNVs will aggre-
gate to certain expected values. Such information could
be incorporated into the model for better signal detec-
tion from background noise. Secondly, more compli-
cated likelihood function, such as a truncated Gaussian,
could be used to handle outliers in genomic copy num-
ber data. Thirdly, informative priors could be used for
better CNV detection. The formation of CNVs in a gen-
ome is potentially affected by many local genomic fea-
tures, such as conservation and repeat content on the
sequence level. Compared with the aforementioned
methods for array-CGH data, our Bayesian approach
has the advantage to readily incorporate such sequence
information through the prior distributions, as it treats
the start and the width of CNVs as parameters and thus
directly models the genomic CNV state. For this initial
Bayesian analysis of genomic copy number data, we
used flat priors for both the CNV start site and width.
However, instead of using such noninformative prior,
we can assign a prior for the start site inversely propor-
tional to the conservation level of the probe sequence.
(This incorporates our belief that the more conserved a
sequence is the less likely it is to be duplicated or
deleted.) For the width, we can assign the width distri-
bution of known CNVs in the database as a prior. The
incorporation of such knowledge through the priors
does not need to be done only once: it can be sequential
(order-insensitive) as more relevant information
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Figure 7 The posterior distribution of model parameters. (A) A view of the posterior probability distribution landscape in the two-
dimensional s1-s2 parameter space. The simulated data D (M = 700) were generated with θ ={ N =2 ,( s1 = 100, w1 = 20, a1 = 2), (s2 = 600, w2 =
20, a2 = - 2), s
2 = 0.4
2}. The posterior probability was evaluated with various combinations of s1 ands2 while all other parameters were kept
fixed at their true values. The terrain color varies from green to yellow to red and then to gray as the posterior probability increases. (B) The
contour of the same posterior distribution. A closed contour line traces points (s1, s2) of equal posterior probability density. As expected, the
global maximum of the posterior probability occurs where s1 = 100 and s2 = 600, two values that were used to generate the underlying data.
Zhang and Gerstein BMC Bioinformatics 2010, 11:539
http://www.biomedcentral.com/1471-2105/11/539
Page 12 of 13becomes available. Using such informative priors, our
method can be seen as a framework that enables inte-
gration of genomic copy number data and the CNV-
related biological knowledge.
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